King Pharmaceuticals News

King Pharmaceuticals, Inc. earned $0.17 per share in the third quarter of 2009, down from $0.34 in the same quarter of last year.

Puget Sound Business Journal ZymoGenetics Inc. said Friday that a federal judge in Tennessee has removed three temporary restraining orders imposed on the company over marketing and promotion of its lead drug, Recothrom.

King Pharmaceuticals, Inc. today announced plans to provide a live webcast of its presentation scheduled for Thursday, November 12, 2009, at 9:00 am Mountain Standard Time , at the Credit Suisse 2009 Healthcare Conference at the Arizona Biltmore Hotel in Phoenix, Arizona.

King Pharmaceuticals, Inc. reported third quarter earnings of 29 cents per share, beating the Zacks Consensus Estimate by 2 cents.

Two years after Mylan Inc. completed a $6.8 billion deal for Merck KGaA's worldwide generic drug business, CEO Robert J. Coury is looking for deals to acquire makers of brand-name drugs.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Main Category: Cardiovascular / Cardiology Also Included In: Regulatory Affairs / Drug Approvals King Pharmaceuticals, Inc.

ROCKVILLE, Md., Oct. 21, 2009--The Food and Drug Administration today posted on its website a warning letter send to King Pharmaceuticals over two Embeda video news releases.

Ilhavo, Portugal a ' 09/10/2009 a ' SADIF Investment Analytics, announces a new summary due diligence report covering Perrigo Company .

On this day, we have begun tracking the following companies as they have shown remarkable correction in recent days, you can access these free reports with a number of other reviews by signing up for your complimentary membership at : http://www.rothmanresearch.com/ Companies been researched today are: Agnico-Eagle Mines Ltd.

Our analysts have issued free ratings reports on the following six companies: Allegheny Technologies Inc.

BRISTOL, Tenn.-- --King Pharmaceuticals, Inc. today announced plans to provide a live webcast of its presentation scheduled for Tuesday, September 22, 2009, at 11:00 a.m. ET, a... 09/17/2009 - 10:20 AM MMC Declares Quarterly Dividend NEW YORK-- --The Board of Directors of Marsh & McLennan Companies, Inc.

King Pharmaceuticals, Inc. today announced plans to provide a live webcast of its presentation scheduled for Tuesday, September 22, 2009, at 11:00 a.m. ET, at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York, New York.

DAVIS, CA and BRIDGEWATER, NJ -- -- 09/11/09 -- AgraQuest Inc. and Alpharma Animal Health announced today that they have agreed to terms for a supply agreement in which AgraQuest will supply their proprietary strain of Bacillus subtilis.

Paula A Cox announced today that Bermuda has been elected Vice Chair of the Steering Group of the new Global Forum at t... LOS ANGELES-- --The Fire Family Foundation announced today that funds are being made available to assist the victims of the fires.

Acura Pharmaceuticals and King Pharmaceuticals Provide Update on Acurox NDA PALATINE, Ill.

DURECT Corporation today reported that it has signed an exclusive long term excipient supply agreement with respect to REMOXY with King Pharmaceuticals, Inc.

Learn the safest practices for medication use and what to ask your doctor. One of the concerns about extended-release opioids like OxyContin is that they are easily abused.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

DURECT Corporation today reported that it has signed an exclusive long term excipient supply agreement with respect to REMOXY with King Pharmaceuticals, Inc.